Undervalued and Undiscovered

[ProfitScout]

$CURR - CURE Pharma's Video: CEO, Rob Davidson, on Leveraging IP for Drug Delivery Platform and Goals for the Rest of 2020
Click here:

About CURE Pharmaceutical Holding Corp.

CURE Pharmaceutical(R) is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.

As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF(R) and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.